bluebird bio, Inc. BLUE Balance Sheet

Bluebird bio, inc. (BLUE)

Balance Sheet / Quarterly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Dec'12
Assets
Current assets:
Cash and cash equivalents
346	327	300	280	221	402	952	333	456	758	237	686	216	278	245	222	192	164	417	593	133	347	89	175	192	206	216	228	67
Marketable securities
564	779	879	972	1,100	982	723	743	665	531	490	409	418	425	355	353	360	353	289	217	201	125	125	-	-	-	-	-	-
Other investment and investment receivable
-	-	-	-	-	-	20	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Tenant improvement receivable
-	-	-	-	-	-	0	0	0	3	2	4	21	8	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Prepaid expenses
40	32	26	25	23	19	24	24	28	21	13	15	8	8	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Receivables and other current assets
16	12	13	21	19	13	5	4	14	8	13	3	3	3	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred tax assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	1	-	3	3	0	0	-	-	-
Prepaid expenses and other current assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	7	7	7	6	4	4	4	6	4	4	2	5	4	1	0
Total current assets
967	1,152	1,220	1,300	1,365	1,418	1,725	1,105	1,164	1,322	758	1,118	667	724	608	582	560	523	713	815	340	479	223	182	195	211	221	230	67
Marketable securities
107	131	225	287	408	506	323	380	444	324	413	101	165	180	126	203	273	347	194	125	134	18	48	-	-	-	-	-	-
Property, plant and equipment, net
153	151	144	129	114	246	232	219	204	199	182	180	181	156	131	109	96	82	61	16	16	15	14	12	11	10	5	2	1
Intangible assets, net
13	14	15	16	12	13	14	15	15	16	17	18	19	20	21	22	23	24	25	26	27	28	29	30	-	-	-	-	-
Goodwill
13	13	13	13	13	13	13	13	13	13	13	13	13	13	13	13	13	13	13	13	13	13	13	13	-	-	-	-	-
Operating lease right-of-use assets
194	185	191	190	184	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Restricted cash and other non-current assets
79	79	82	84	40	44	42	28	24	23	19	24	24	22	16	10	10	10	10	1	1	1	1	1	1	1	1	1	0
Total assets
1,529	1,727	1,892	2,023	2,138	2,242	2,351	1,761	1,866	1,900	1,405	1,457	1,072	1,118	918	941	978	1,002	1,017	999	533	556	330	240	209	224	228	234	69
Current liabilities:
Accounts payable
30	42	41	29	30	17	12	17	12	12	12	14	8	13	6	2	3	6	3	2	2	2	3	2	2	4	1	1	2
Accrued expenses and other current liabilities
118	141	112	91	76	99	88	71	61	57	42	43	44	54	54	31	29	28	24	20	15	14	9	11	5	5	5	3	2
Operating lease liability, current portion
20	20	19	18	17	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred revenue, current portion
6	8	8	9	11	18	22	27	34	25	21	19	19	6	6	6	6	5	5	5	24	25	25	25	25	25	25	25	0
Collaboration research advancement, current portion
9	10	13	13	11	10	7	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total current liabilities
184	223	196	162	146	146	131	116	107	95	76	77	72	74	67	40	38	40	33	28	42	42	38	39	33	34	31	30	4
Deferred revenue, net of current portion
9	9	11	13	14	16	22	27	28	21	27	19	22	40	41	43	44	35	37	38	-	5	11	17	23	30	36	42	0
Collaboration research advancement, net of current portion
26	27	26	28	30	33	37	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Warrant liability
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0
Deferred rent, net of current portion
-	-	-	-	-	-	-	-	-	-	2	2	10	10	10	8	8	8	8	8	8	8	8	8	7	6	2	0	0
Contingent consideration
4	7	6	5	5	5	3	3	2	2	2	3	3	3	3	3	5	5	4	4	6	6	6	6	-	-	-	-	-
Operating lease liability, net of current portion
179	170	176	175	168	153	153	154	154	154	154	153	147	120	99	86	74	61	43	-	-	-	-	-	-	-	-	-	-
Deferred tax liabilities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	1	-	3	3	0	0	-	-	-
Other non-current liabilities
2	2	3	1	0	3	2	2	2	2	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	-	-	-
Total liabilities
408	442	420	386	366	357	350	303	296	277	264	257	257	248	223	182	172	151	128	80	59	65	68	74	65	72	70	73	5
Commitments and contingencies (Note 8)
-	-	-	-	-	-	0	0	0	-	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Stockholders’ equity:
Preferred stock, $0.01 par value, 5,000 shares authorized; 0 shares issued and outstanding at March 31, 2020 and December 31, 2019
0	0	-	-	-	0	0	0	0	-	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	0
Common stock, $0.01 par value, 125,000 shares authorized; 55,620 and 55,368 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Additional paid-in capital
3,607	3,568	3,532	3,489	3,430	3,386	3,355	2,666	2,633	2,540	1,939	1,918	1,463	1,447	1,201	1,188	1,177	1,166	1,155	1,142	646	638	389	276	253	250	248	245	15
Accumulated other comprehensive loss
-2	-1	-2	-0	-1	-3	-5	-5	-5	-4	-2	-1	-1	-1	-0	-0	-0	-2	0	-0	-0	-0	-0	-	-	-	-	-	-
Accumulated deficit
-2,480	-2,281	-2,058	-1,852	-1,656	-1,498	-1,349	-1,204	-1,058	-913	-796	-717	-646	-577	-506	-429	-370	-314	-266	-223	-172	-147	-127	-110	-109	-98	-90	-84	-73
Total stockholders’ equity
1,120	1,284	1,471	1,636	1,772	1,885	2,000	1,457	1,570	1,623	1,141	1,200	815	869	694	759	806	850	889	918	474	491	261	165	144	151	157	161	-55
Total liabilities and stockholders’ equity
1,529	1,727	1,892	2,023	2,138	2,242	2,351	1,761	1,866	1,900	1,405	1,457	1,072	1,118	918	941	978	1,002	1,017	999	533	556	330	240	209	224	228	234	69